End-Stage Renal Disease (ESRD) Treatment Market

End-Stage Renal Disease (ESRD) Treatment Market to Witness Growth due to Rising Incidence of Chronic Kidney Diseases

by

The end-stage renal disease (ESRD) treatment market has witnessed significant growth in recent years. ESRD or kidney failure is the last stage of chronic kidney disease (CKD), where the kidneys permanently stop working. ESRD requires kidney replacement therapy in the form of dialysis or kidney transplantation to survive. Hemodialysis (HD) and peritoneal dialysis (PD) are the most common treatment options for ESRD.

 

The global End-Stage Renal Disease Treatment Market is estimated to be valued at US$ 98.27 billion in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031.

 

Rising prevalence of chronic diseases such as diabetes and hypertension that can damage kidneys, increasing geriatric population, growing awareness about treatment, and improving reimbursement policies are fueling market growth.

Key Takeaways

Key players operating in the end-stage renal disease (ESRD) treatment market are Fresenius Medical Care, DaVita Inc., Baxter, B. Braun Melsungen AG, and Asahi Kasei Medical.

The market is witnessing significant opportunities due to the increasing demand for home-based dialysis treatment. Home dialysis offers higher patient convenience and satisfaction as compared to in-center hemodialysis. The growing focus on home-based dialysis therapies is projected to boost market revenues.

With increasing burden of CKD and shortage of kidneys for transplantation, there is immense potential for market expansion in developing regions. Major players are focusing their efforts on countries in Asia, Latin America, Middle East, and Africa through acquisitions, partnerships, and by strengthening their distribution networks.

Market Drivers

Rising incidence of chronic kidney diseases such as diabetes and hypertension are majorly driving the need for ESRD treatment. According to the National Kidney Foundation, over 37 million Americans suffer from CKD, with around 100,000 new cases of kidney failure occurring each year in the US. Further, advancements in dialysis technologies, introduction of home-based dialysis products, and growing awareness about transplantation and dialysis are some key factors fueling the demand for ESRD treatment worldwide.

PEST Analysis

Political: The health policies and regulations across various regions impact the growth of this market. Reimbursement policies for different treatment options influence demand.

Economic: The rising costs of ESRD treatments pose a financial burden on patients. Economic growth influences healthcare budgets and thereby market growth.

Social: Growing prevalence of diabetes and hypertension increase the risk of kidney diseases. Awareness campaigns help patients understand treatment options and take preventive measures.

Technological:
Advances in peritoneal dialysis solutions and equipment improve treatment effectiveness and convenience. Home hemodialysis using portable systems enhances accessibility. Development of newer kidney transplantation techniques and drugs expand the therapeutic landscape.

Geographical concentration: North America currently holds the largest share of the global ESRD treatment market, owing to established healthcare infrastructure and high spending on chronic disease management. The availability of advanced treatment options and procedures further drive the regional market.

Fastest growing region: Asia Pacific is projected to experience the highest growth during the forecast period due to rising incidence of diabetes and hypertension, improving access to healthcare facilities, and growing healthcare expenditure of countries like China and India. Increasing awareness about kidney diseases and their treatment options also supports regional market expansion.

What Are The Key Data Covered In This End-Stage Renal Disease Treatment Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the End-Stage Renal Disease Treatment’s growth between 2024 and 2031.

:- Accurate calculation of the size of the End-Stage Renal Disease Treatment and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- End-Stage Renal Disease Treatment Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of End-Stage Renal Disease Treatment vendors

 

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

About Author – Money Singh
+ posts

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.  LinkedIn Profile